{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:40:36Z","timestamp":1792201236441,"version":"4.4.0"},"reference-count":19,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":3487,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To compare associations of maternal glucose and A1C with adverse outcomes in the multinational Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and determine, based on those comparisons, if A1C measurement can provide an alternative to an oral glucose tolerance test (OGTT) in pregnant women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Eligible pregnant women underwent a 75-g OGTT at 24\u201332 weeks\u2019 gestation. A sample for A1C was also collected. Neonatal anthropometrics and cord serum C-peptide were measured. Associations with outcomes were assessed using multiple logistic regression with adjustment for potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Among 23,316 HAPO Study participants with glucose levels blinded to caregivers, 21,064 had a nonvariant A1C result. The mean \u00b1 SD A1C was 4.79 \u00b1 0.40%. Associations were significantly stronger with glucose measures than with A1C for birth weight, sum of skinfolds, and percent body fat &amp;gt;90th percentile and for fasting and 1-h glucose for cord C-peptide (all P &amp;lt; 0.01). For example, in fully adjusted models, odds ratios (ORs) for birth weight &amp;gt;90th percentile for each measure higher by 1 SD were 1.39, 1.45, and 1.38, respectively, for fasting, 1-, and 2-h plasma glucose and 1.15 for A1C. ORs for cord C-peptide &amp;gt;90th percentile were 1.56, 1.45, and 1.35 for glucose, respectively, and 1.32 for A1C. ORs were similar for glucose and A1C for primary cesarean section, preeclampsia, and preterm delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>On the basis of associations with adverse outcomes, these findings suggest that A1C measurement is not a useful alternative to an OGTT in pregnant women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc11-1687","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T16:14:00Z","timestamp":1328199240000},"page":"574-580","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":245,"title":["Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study"],"prefix":"10.2337","volume":"35","author":[{"given":"Lynn P.","family":"Lowe","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyd E.","family":"Metzger","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Dyer","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, John Hunter Hospital, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"McCance","sequence":"additional","affiliation":[{"name":"Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital Belfast, Belfast, Northern Ireland, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence R.J.","family":"Lappin","sequence":"additional","affiliation":[{"name":"Department of Haematology, Queen\u2019s University Belfast, Belfast, Northern Ireland, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth R.","family":"Trimble","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Queen\u2019s University Belfast, Belfast, Northern Ireland, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Coustan","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Warren Alpert Medical School, Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Hadden","sequence":"additional","affiliation":[{"name":"Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital Belfast, Belfast, Northern Ireland, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Hod","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center\u2013Sackler Faculty of Medicine, Tel-Aviv University, Petah-Tiqva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.N.","family":"Oats","sequence":"additional","affiliation":[{"name":"Department of Obstetric Medicine, Mater Misericordiae Mothers\u2019 Hospital\u2013University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Persson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the HAPO Study Cooperative Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2012,2,10]]},"reference":[{"key":"2022031220011297600_B1","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031220011297600_B2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","author":"International Expert Committee","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031220011297600_B3"},{"key":"2022031220011297600_B4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9378(84)90420-4","article-title":"Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy","volume":"150","author":"Cousins","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"2022031220011297600_B5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0002-9378(82)90350-7","article-title":"Comparison of glycohemoglobin determination and the one-hour oral glucose screen in the identification of gestational diabetes","volume":"144","author":"Shah","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"2022031220011297600_B6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2007-1009154","article-title":"The role of serum fructosamine as a screening test for gestational diabetes mellitus","volume":"21","author":"Vermes","year":"1989","journal-title":"Horm Metab Res"},{"key":"2022031220011297600_B7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1464-5491.1995.tb00574.x","article-title":"An evaluation of fructosamine estimation in screening for gestational diabetes mellitus","volume":"12","author":"Hughes","year":"1995","journal-title":"Diabet Med"},{"key":"2022031220011297600_B8","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0002-9378(11)91719-0","article-title":"Glycated hemoglobin of fractionated erythrocytes, glycated albumin, and plasma fructosamine during pregnancy","volume":"167","author":"Kurishita","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2022031220011297600_B9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031220011297600_B10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0020-7292(02)00092-9","article-title":"The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study","volume":"78","author":"HAPO Study Cooperative Research Group","year":"2002","journal-title":"Intl J Gynaecol Obstet"},{"key":"2022031220011297600_B11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1740774506070695","article-title":"Integration of local and central laboratory functions in a worldwide multicentre study: Experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study","volume":"3","author":"Nesbitt","year":"2006","journal-title":"Clin Trials"},{"key":"2022031220011297600_B12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF00292540","article-title":"Haemolysis affects insulin but not C-peptide immunoassay","volume":"30","author":"O\u2019Rahilly","year":"1987","journal-title":"Diabetologia"},{"key":"2022031220011297600_B13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/db08-1112","article-title":"Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics","volume":"58","author":"HAPO Study Cooperative Research Group","year":"2009","journal-title":"Diabetes"},{"key":"2022031220011297600_B14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2006-931912","article-title":"Population meta-analysis of low plasma glucose thresholds in full-term normal newborns","volume":"23","author":"Alkalay","year":"2006","journal-title":"Am J Perinatol"},{"key":"2022031220011297600_B15","doi-asserted-by":"crossref","first-page":"IX","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"2022031220011297600_B16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/0002-9378(95)91348-3","article-title":"Anthropometric estimation of neonatal body composition","volume":"173","author":"Catalano","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2022031220011297600_B17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":"International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031220011297600_B18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00125-010-2005-4","article-title":"Diagnosing gestational diabetes","volume":"54","author":"Ryan","year":"2011","journal-title":"Diabetologia"},{"key":"2022031220011297600_B19","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00125-011-2228-z","article-title":"Diagnosing gestational diabetes: can expert opinions replace scientific evidence?","volume":"54","author":"Long","year":"2011","journal-title":"Diabetologia"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/35\/3\/574\/610414\/574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/35\/3\/574\/610414\/574.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T16:48:44Z","timestamp":1647103724000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/35\/3\/574\/28802\/Hyperglycemia-and-Adverse-Pregnancy-Outcome-HAPO"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,10]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,2,10]]},"published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc11-1687","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,10]]}}}